Your browser doesn't support javascript.
loading
Low-density lipoprotein cholesterol reduction and target achievement after switching from statin monotherapy to statin/ezetimibe combination therapy: Real-world evidence.
Lee, Jeongmin; Lee, Sue Hyun; Kim, Hyunah; Lee, Seung-Hwan; Cho, Jae Hyoung; Lee, Hyunyong; Yim, Hyeon Woo; Yoon, Kun-Ho; Kim, Hun-Sung; Kim, Ju Han.
Afiliación
  • Lee J; Division of Endocrinology and Metabolism, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Lee SH; Department of Biomedical Informatics, College of Medicine, Konyang University, Daejeon, Korea.
  • Kim H; College of Pharmacy, Sookmyung Women's University, Seoul, Republic of Korea.
  • Lee SH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Cho JH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Lee H; Clinical Research Coordinating Center, Catholic Medical Center, The Catholic University of Korea, Seoul, Republic of Korea.
  • Yim HW; Department of Preventive Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Yoon KH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Kim HS; Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Kim JH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
J Clin Pharm Ther ; 46(1): 134-142, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33026659

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Ezetimiba / Hipercolesterolemia / LDL-Colesterol Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: J Clin Pharm Ther Asunto de la revista: FARMACIA / TERAPEUTICA Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Ezetimiba / Hipercolesterolemia / LDL-Colesterol Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: J Clin Pharm Ther Asunto de la revista: FARMACIA / TERAPEUTICA Año: 2021 Tipo del documento: Article